Clinical trial readiness to solve barriers to drug development in FSHD (ReSolve): protocol of a large, international, multi-center prospective study.

Samantha LoRussoNicholas E JohnsonMichael P McDermottKaty EichingerRussell J ButterfieldElena CarraroKiley HiggsLeann LewisKarlien MulSabrina SacconiValeria A SansonePerry ShiehBaziel van EngelenKathryn WagnerLeo WangJeffrey M StatlandRabi Tawilnull null

Published in: BMC neurology (2019)

clinicaltrials.gov NCT03458832; Date of registration: 1/11/2018.

Keyphrases

clinical trial
randomized controlled trial
phase ii
study protocol
open label
double blind
phase iii
placebo controlled